Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors' potential to spread, and may even be targets for future prostate ...

Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.

Putative biomarkers in malignant pleural mesothelioma. ERCC1 and class III β-tubulin expression in chemotherapy-naive advanced non-small cell lung cancer patients treated with cisplatin and ...

In many cancers, not all areas of the tumor are the same; this is said to be “heterogeneous”. This is a process that occurs progressively. This can arise through genomic alterations (mutations and ...

TAMPA, Fla. -- Prostate cancer is the most common cancer in men. One in nine men will be diagnosed during their lifetime. While most men will not die from prostate cancer, there is a small subset of ...

The effect of a home-based walking exercise program among men with prostate cancer receiving androgen deprivation therapy: A feasibility trial. Background: Few resources exist with the ability to ...

California researchers say it may be possible to test the non-cancerous part of the prostate to detect prostate cancer (PCa), a novel approach that may aid in localization of cancer lesions within the ...

Johns Hopkins Kimmel Cancer Center researchers from the Department of Radiation Oncology and Molecular Radiation Sciences identified a lipid-regulating protein that conveys what the researchers ...

Benign prostatic hyperplasia (BPH) is an extremely common disease of older men, occurring in more than 70 percent of men over the age of 60. BPH results in substantial morbidity in this patient ...

A team of scientists at the Research Institute of the McGill University Health Center (The Institute) has made a landmark discovery that sheds light on how the immune system protects the gut during ...